Saturday, November 17, 2012
Print Current Session:
|
|
Saturday
SESSION 45:
LUNCHEON SESSION: NEW OR IMPROVED ENDOVASCULAR DEVICES (5-MINUTE TALKS)
Moderators:Eric L.G. Verhoeven, MD, PhD / Juan C. Parodi, MD
|
|
SESSION 45 SCHEDULE | |
12:01 PM - 12:06 PM | Off-The-Shelf Fenestrated VENTANA Device For Renal Revascularization With Juxta And Pararenal AAAs: Clinical Update And Will In Situ Fenestration Be Possible With Newer Multilayer Stretchable PTFE Endograft Coverings |
Presenter(s):Daniel G. Clair, MD | |
12:07 PM - 12:12 PM | Recent Improvements In The Cook Zenith AAA Endograft: How Do They Make A Difference |
Presenter(s):Tara M. Mastracci, MD | |
12:13 PM - 12:18 PM | Update On Advantages And Limitations Of The Lombard AORFIX Graft: When Will It Be Approved In The US |
Presenter(s):Brian R. Hopkinson, ChM, FRCS / Mark F. Fillinger, MD | |
View Abstract | |
12:19 PM - 12:24 PM | Worldwide Experience With The Aptus HELIFX Endostaples: Can They Fix Endoleaks And Prevent Aortic Neck Enlargement And Migration |
Presenter(s):David H. Deaton, MD | |
12:25 PM - 12:30 PM | Update On The NELLIX Device For EVAR: Advantages And Limitations |
Presenter(s):Jeffrey P. Carpenter, MD | |
12:31 PM - 12:36 PM | Advantages And Limitations Of The INCRAFT From Cordis: 1-Year Clinical Data From The INNOVATION Trial |
Presenter(s):Gioacchino Coppi, MD / Dierk Scheinert, MD | |
12:37 PM - 12:42 PM | Description And Clinical Experience With The Anaconda Fenestrated Endograft For Juxta And Pararenal AAAs |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
12:43 PM - 12:48 PM | Worldwide Mid-Term Results (2-Year) Of The Endurant Endograft For AAAs: Does It Expand The Proportion Of Patients Who Can Undergo EVAR Safely And Effectively |
Presenter(s):Dittmar Boeckler, MD / Michel S. Makaroun, MD | |
12:49 PM - 12:54 PM | Current Status Of The Bolton TREOVANCE AAA Endograft: Advantages And Limitations |
Presenter(s):Edward Y. Woo, MD / Ronald M. Fairman, MD | |
12:55 PM - 1:00 PM | Panel Discussion |
END OF SESSION 45 | |
previous | next |